Tetramatrix is a flowable biomaterial that forms an adhesive and biomimetic scaffold when administered to the body. Tetramatrix hydrogel provides an optimal environment for cell infiltration and blood vessel ingrowth to complement the innate healing process across different tissues and therefore provides a true regenerative platform. The core technology of the platform is a smart polymer that consists of 4 key building blocks to deliver 4 key properties which in combination makes the technology unique.
As a world-class researcher with decades of experience in translational research, Simin manages and drives our production program. Combining both a calm temperament and a meticulous nature, Simin is our production and research North Star.
Ruth has unparalleled experience in the quality and regulatory functions of the global medical device industry, which are critical in her role to obtain registration and market clearance for Tetramatrix. Ruth has a unique ability to be both dynamic and meticulous in how she applies her skill set – a rarity in the industry.
Will provides the commercial context to define and deliver the Tetratherix mission, vision and culture. Will’s prior success in commercialisation and development of life-changing MedTech innovations are paramount to the company’s global ambitions.
As a clinician and a driven researcher, Jo’s unique skill set facilitates effective engagement and collaboration with key opinion leaders to define the clinical utility of Tetramatrix. Jo is hardworking, diligent and precise, making her an integral part of the team.
Ali is a world-renowned researcher and inventor of Tetramatrix and has continued the development of the technology using his technical and entrepreneurial vision. Ali’s scientific approach to problem-solving and his tenacity are central to bringing the technology into the hands of clinicians.
Kim’s proficient and driven management of our clinical trial program has enabled us to establish an adoptable and efficient cadence in our clinical validation. Her calm and confident decision-making complements her ability to energise those around her.
As an engineer, Terence is armed with the experience and understanding of bespoke chemical manufacturing. A natural problem solver with the ability to think outside the box, Terence has been instrumental in process design and optimisation to allow production of Tetramatrix at scale.
Jeff’s decades of experience in successful commercialisation of medical innovations forms a platform that helps to define our commercial development program, including key partnership management and pipeline strategy. Jeff’s extensive knowledge of execution and accountability in the market ensures that our development program meets our commercial objectives.
Dax is a specialist periodontist with a passion to simplify and improve techniques relating to dental implant surgeries and bone augmentation procedures. Dax is a long-time supporter of Tetratherix and was the first surgeon to explore Tetramatrix in a clinical setting.
For nearly a decade, Rob has been ranked as Australia’s highest recommended patent and technology licensing lawyer. He specializes in the commercialisation of novel technologies, and in aspects of major corporate transactions related to intellectual property.
Ali is the CEO of the Terasaki Institute and former Professor at the University of California, Los Angeles, Harvard Medical School and the Wyss Institute for Biologically Inspired Engineering. Ali has been selected by Thomson Reuters as one of the World’s Most Influential Minds since 2014.
Drew is a board-certified plastic and reconstructive surgeon with a passion for complex skin cancer excision and surgical reconstruction. Drew has been the winner of the prestigious Emmett Prize for most outstanding registrar research in Australia and New Zealand.
Tetramatrix is a liquid scaffold which forms an adhesive matrix that matches the geometry of skin defects. It provides a cell-permeable bridge to promote wound closure and reduce scar formation in hard-to-heal wounds.
Tetramatrix is mixed with bone graft or biologic agents to immobilise the incorporated compound at the site. This allows controlled delivery, more structural stability and predictable clinical outcomes.
Tetramatrix is a ready-to-use biostimulatory filler with unique physical properties that allow physicians to achieve an optimal aesthetic outcome. Tetramatrix stimulates the natural regeneration of dermal tissue for a more permanent aesthetic solution.
Tetramatrix is a unique carrier system that enables effective and controlled delivery of therapeutic molecules. Tetramatrix is able to form aerosols and injectable formulations for nasal delivery or targeted injection.
When in 2009 Dr Ali Fathi was told his broken wrist would require surgery, he asked his surgeon whether instead of going under the knife if there was a glue that could hold his fracture in place allowing it to heal naturally. He couldn’t believe the answer was no….
Tetratherix is pleased to announce the appointment of Will Knox to the role of Chief Executive Officer (CEO) effective immediately. Will brings to Tetratherix 20 years of strong leadership and entrepreneurial experience, having worked on the development and commercialisation of medical technologies for multiple as well as early-stage developers…